Wednesday, June 16, 2010

Despite evidence patients Want more health care

Categories: Hospitals, rules, Doctors04: 40 pmJune 3, 2010E-mail share print comments () Facebook stumble Upon Reddit Twitter Feed what's this? participation By Julie Rovner istockphoto.com man putting fingers in his ears

When the experts say about effective medical treatment, patients are not listening.

However, it was articulated inartfully theme Central Administration Obama push for health care and health experts on the lips for years: more healthcare is not necessarily better care.

However, far from being satisfied patients.

Health Affairs Journal just tested more than 1,500 patients with insurance offered by the employer, including dozens of thematic groups and individual interviews.

"Pervasive Themes" from respondents, according to the authors, were "better is more newer is better, you get what you pay for (I) Guidelines restrict My doctor provide me with caution and need and deserve."

Such findings are frustrating for experts, who have spent years trying to communicate that these things are not met and they actually endanger its efforts to change hospital and physician payments to reward quality. they also consumers from seeking higher quality and more cost-effective care, say researchers.

"For those who believe that all healthcare meets minimum standards and that more care is better, the distinction between physicists, hospitals or other suppliers on the basis of quality and efficiency of profiles is likely to meet with resistance," they write.

Your own study shows that only 41% of respondents agree that workers should pay less if they doctors who rank highly in quality measures.In addition, only 47% thought that workers should pay less for treatment, which has been shown.

Of course, doesn't help their education efforts that the Republicans have been hammering on new health rights "comparative effectiveness" provisions, call their democratic efforts to ration health care.

Still those pushing use of evidence-based medicine are resigning.

Examination by the authors have developed toolkit communications to help employers and unions, better clarify concepts related to health care quality and cost-effectiveness of patients is available in the business group, national Health's website.

E-mail (share print comments) Facebook stumble Upon Reddit Twitter Feed what's this?share & nbsp comments on this thread now discussions are closed. Please see the FAQ for more information. Recent First Oldest first most recommended view all comments» < previous="" post="" next="" post=""> search Shots-Health News Blog Blog host A caricature of Scott Hensley. tu HensleyPolitical Editor appears Scott--> text.--> What is ' Shots '?

This blog covers news about health and medicine; it is written and submitted by NPR's Science Desk.

For more information about blog check out Shots FAQ and be sure to read our rules before joining the discussion on the conversation here.

Contact us

You can drop the team goes to note using our contact form.

social mediaNPR Health Twitter Feed. twtr-hd,. twtr-ft {display: none;}. twtr-tweets {border-top: 1px dotted # ddd;} podcast on health Podcast

Detailed reports on medicine, staying healthy and the major issues surrounding health care.

SubscribePodcast + RSS RSS Podcast Shots-Blog Health News

Subscribe to Shots-Health News Blog podcast by:

iTunesZune

Or use this URL:

This podcast

closeJulie Rovner

Subscribe to podcast Julie Rovner through:

iTunesZune

Or use this URL:

This podcast

closeAccess Archived Stories January February March April May June July August September October November December 201020092008200720062005200420032002200120001999199819971996199519941993 Blog Categories Aging Cancer Children's health Disabilities Doctors FDA fitness & Nutrition disease & Stroke Hospitals Infectious Disease insurance international Health medical devices Medicare & Medicaid Men's health mental health Pharmaceuticals Policy public health & Prevention Research Vaccines Women's health Your Health npr always on Newsletters, RSS Feeds Podcasts Mobile Widgets API Radio news U.S. World Opinion Politics business technology Science Health Sports arts & life Books Movies Pop Culture Food performing arts games & Humor music Concerts you Hear This Interviews & Profiles Music News Music BlogsRock/Pop/FolkJazz & BluesClassical Browse Artists a-z All Songs ConsideredFrom's JazzSet Marian McPartland's Piano Jazz Mountain StageSong of the DayThe Thistle & Shamrock World Cafe world of Opera programs a-z Morning Edition, All Things Considered Fresh Air The Diane Rehm Show on the media on Point talk of the Nation embedded Weekend Edition Saturday Weekend Edition Sunday Car Talk Wait Wait ... don't tell me! Listen hourly News NPR Program Stream schedule find station streams more multimedia column blogs Analysis comment NPR Ombudsman topics index sponsor NPR NPR Shop On NPR Jobs & training newspaper Copyright NPR conditions of Use privacy policy permissions correct Text-Only site contact us grants Our partner in broadcastingpbs

Future Looks Blurry For Comparative Effectiveness Research

Categories: Medicare & Medicaid, Policy, Aging, Pharmaceuticals

03:59 pm

June 4, 2010

E-mail Share Print Comments () Facebook Stumble Upon Reddit Twitter Digg What is this?

Share   by Julie Rovner

Here's one head-to-head drug test that should have been a slam-dunk and wasn't.

Intermediate age-related macular degeneration National Eye Institute/Wikimedia Commons

The mottled pattern in this picture indicates age-related macular degeneration.

A few years back the government funded a clinical study of two drugs — one very expensive and the other not so much — to treat a leading cause of blindness. But the problems along the way should give everyone pause about how hard it will really be to figure out which medicines and treatments are better values, the idea behind so-called comparative effectiveness research.

At issue are two treatments for age-related macular degeneration. In 2005, the FDA approved Genentech's Lucentis, a modified cancer drug, as the first-ever treatment for so-called wet AMD. The big downside? It costs $2,000 for a monthly dose.

Almost immediately, opthalmologists began using Avastin, the original cancer drug also from Genentech, which wasn't approved for macular degeneration, instead. It cost only $50 per dose, and doctors who used it said it appeared to work just as well.

With the obvious need for a head-to-head comparison, particularly since 95 percent of wet AMD patients are on Medicare and thus treated at taxpayer expense, the National Eye Institute approved funding of a clinical study, called CATT for short, in 2006.

But that was the last part of the process that was simple, some of the study's lead researchers write in a piece in this week's New England Journal of Medicine. "Our experience with CATT highlights important roadblocks and dramatic changes needed in federal infrastructure for (comparative effectiveness research) to be conducted efficiently," wrote the authors from the Cleveland Clinic and University of Pennsylvania.

The first obstacle came in figuring out who would pay for the drugs when there was no drug company to sponsor the research. Existing Medicare policy didn't allow payment for the drugs; it took a specific change in policy which didn't happen until 2007.

Then there was the problem of patient co-payments. The differential was obviously enormous between a drug that costs $2,000 a dose and one that costs $50 per dose, presenting a challenge not just for recruiting patients who would not want to be in the more expensive group, but for keeping the research "blind." In other words, even patients with supplemental insurance would be getting "explanation of benefits" statements that would make it clear which drug they were getting.

Eventually, Congress passed a bill to create payment mechanisms needed to carry out such trials; a bill that didn't pass until July 2008. That came too late for the CATT study, which finally got underway in early 2008, and reached its patient capacity in late 2009.

But the delays weren't without cost, the authors noted. "The roadblocks delayed study initiation by more than a year, while another 200,000 patients and their doctors had to make decisions without important information about relative efficacy and safety," they wrote.

And without a more comprehensive policy to cover both federal and private insurers about who will pay for drugs being tested in such trials, they note, "it is difficult to imagine that the $1.1 billion" included in the 2009 stimulus bill for comparative effectiveness research "will be used effectively."

E-mail Share Print Comments () Facebook Stumble Upon Reddit Twitter Digg What is this?

Share     Comments Discussions for this story are now closed. Please see the Community FAQ for more information.

  Recent First Oldest First Most Recommended View all comments »

< previous post next post > Search Shots - Health News Blog Blog HostA caricature of Scott Hensley.Scott HensleyPolitical Editor

-->Text goes here.

--> What Is 'Shots'?

This blog covers news about health and medicine. It is written and reported by NPR's Science Desk.

For more about the blog, check out the Shots FAQ. And be sure to read our discussion rules before joining in on the conversation here.

Contact Us

You can drop the Shots team a note via our contact form.

social mediaNPR Health Twitter Feed.twtr-hd, .twtr-ft {display:none;}.twtr-tweets {border-top:1px dotted #ddd;} podcastOn Health Podcast

In-depth reports on medicine, staying healthy and the major issues surrounding health care.

Subscribe

Podcast + RSS Feeds Podcast RSS Shots - Health News Blog

Subscribe to Shots - Health News Blog podcast via:

iTunesZune

Or use this URL:

This podcast

close

    Health Care

Subscribe to Health Care podcast via:

iTunesZune

Or use this URL:

This podcast

close

      Access Archived Stories January February March April May June July August September October November December 201020092008200720062005200420032002200120001999199819971996199519941993 Blog Categories Aging Cancer Children's Health Disabilities Doctors FDA Fitness & Nutrition Heart Disease & Stroke Hospitals Infectious Disease Insurance International Health Medical Devices Medicare & Medicaid Men's Health Mental Health Pharmaceuticals Policy Public Health & Prevention Research Vaccines Women's Health Your Health   npr always on Newsletters Podcasts Mobile RSS Feeds Widgets API Radio news U.S. World Opinion Politics Business Technology Science Health Sports arts & life Books Movies Pop Culture Food Performing Arts Games & Humor music Concerts You Must Hear This Interviews & Profiles Music News Music BlogsRock/Pop/FolkJazz & BluesClassical Browse Artists A-Z All Songs ConsideredFrom The Top JazzSet Marian McPartland's Piano Jazz Mountain StageSong of the DayThe Thistle & Shamrock World Cafe World Of Opera programs a-z Morning Edition All Things Considered Fresh Air The Diane Rehm Show On The Media On Point Talk of the Nation Tell Me More Weekend Edition Saturday Weekend Edition Sunday Car Talk Wait Wait...Don't Tell Me! listen Hourly News NPR Program Stream Schedule Find Station Streams more Multimedia Columns Blogs Analysis Commentary NPR Ombudsman Topic Index Sponsor NPR NPR Shop About NPR Jobs & Training Press Releases Copyright NPR Terms of Use Privacy Policy Permissions Corrections Text-Only Site Help Contact Us Donate Our partner in public broadcasting pbs

Gates Foundation Pledges $1.5 Billion To Child And Maternal Health

Categories: International Health, Women's Health, Public Health & Prevention, Children's Health

03:00 pm

June 7, 2010

E-mail Share Print Comments () Facebook Stumble Upon Reddit Twitter Digg What is this?

Share   by Whitney Blair Wyckoff

June 7, 2010

Listen to the Story All Things Considered

[5 min 7 sec] Add to Playlist Download Transcript   UN Secretary-General Ban Ki-moon and Melinda Gates discuss maternal and child health. Enlarge Haraz N. Ghanbari/AP

Melinda Gates discusses maternal and child health at a womens' health conference in Washington on Monday.

UN Secretary-General Ban Ki-moon and Melinda Gates discuss maternal and child health. Haraz N. Ghanbari/AP Melinda Gates discusses maternal and child health at a womens' health conference in Washington on Monday.

What's the next big focus of the Bill & Melinda Gates Foundation? Maternal health.

Melinda Gates announced today the Foundation will invest $1.5 billion over the next five years in programs promoting maternal and child health, family planning, and nutrition in developing countries.

"We said AIDS is important, we said malaria is important, we're saying now maternal and child deaths are important — and guess what?  It's actually possible to fix them," Gates told NPR All Things Considered Host Michele Norris.

The move comes at a time when AIDS activists are expressing concern that the U.S. is stretching foreign aid programs without putting a lot more dollars into the pot.

Gates said that in a lot of the communities she's visited, women are very vocal about wanting access to birth control.

She doesn't think there is as much of a cultural obstacle as it might seem to some Americans.

"I actually think the biggest barrier is sometimes the American public," she said.  "The way we think about reproductive rights is pretty different than the European women do or the women I meet in Africa and even the governments in Africa."

"We make it a big debate, and it really shouldn't be," she said. (Click here for Gates on birth control in her own words.)

Researchers funded by the Gates Foundation recently found that the number of maternal deaths has declined from 526,300 in 1980 to 342,900 in 2008. They attribute the improvement to a decline in birth rates, better educated women, higher incomes and better care at the time of delivery.

But there's still work to be done. Ninety-nine percent of maternal deaths happen in developing countries, according to the World Health Organization. The worst? In Afghanistan, the maternal death rate is 1,575 deaths per 100,000 births. (See a spreadsheet with recent country rankings here.)

Gates tried to steer clear of the abortion issue when she announced the grant at the "Women Deliver" conference in Washington, D.C., although Norris noted the conference calls for safe and legal abortions.

"We don't want to be part of the controversy or stem that controversy," Gates said. Giving women family planning tools can reduce the demand for abortions, she added.

E-mail Share Print Comments () Facebook Stumble Upon Reddit Twitter Digg What is this?

Share     Comments Discussions for this story are now closed. Please see the Community FAQ for more information.

  Recent First Oldest First Most Recommended View all comments »

< previous post next post > Search Shots - Health News Blog Blog HostA caricature of Scott Hensley.Scott HensleyPolitical Editor

-->Text goes here.

--> What Is 'Shots'?

This blog covers news about health and medicine. It is written and reported by NPR's Science Desk.

For more about the blog, check out the Shots FAQ. And be sure to read our discussion rules before joining in on the conversation here.

Contact Us

You can drop the Shots team a note via our contact form.

social mediaNPR Health Twitter Feed.twtr-hd, .twtr-ft {display:none;}.twtr-tweets {border-top:1px dotted #ddd;} podcastOn Health Podcast

In-depth reports on medicine, staying healthy and the major issues surrounding health care.

Subscribe

Podcast + RSS Feeds Podcast RSS Shots - Health News Blog

Subscribe to Shots - Health News Blog podcast via:

iTunesZune

Or use this URL:

This podcast

close

    World Health

Subscribe to World Health podcast via:

iTunesZune

Or use this URL:

This podcast

close

      Access Archived Stories January February March April May June July August September October November December 201020092008200720062005200420032002200120001999199819971996199519941993 Blog Categories Aging Cancer Children's Health Disabilities Doctors FDA Fitness & Nutrition Heart Disease & Stroke Hospitals Infectious Disease Insurance International Health Medical Devices Medicare & Medicaid Men's Health Mental Health Pharmaceuticals Policy Public Health & Prevention Research Vaccines Women's Health Your Health   npr always on Newsletters Podcasts Mobile RSS Feeds Widgets API Radio news U.S. World Opinion Politics Business Technology Science Health Sports arts & life Books Movies Pop Culture Food Performing Arts Games & Humor music Concerts You Must Hear This Interviews & Profiles Music News Music BlogsRock/Pop/FolkJazz & BluesClassical Browse Artists A-Z All Songs ConsideredFrom The Top JazzSet Marian McPartland's Piano Jazz Mountain StageSong of the DayThe Thistle & Shamrock World Cafe World Of Opera programs a-z Morning Edition All Things Considered Fresh Air The Diane Rehm Show On The Media On Point Talk of the Nation Tell Me More Weekend Edition Saturday Weekend Edition Sunday Car Talk Wait Wait...Don't Tell Me! listen Hourly News NPR Program Stream Schedule Find Station Streams more Multimedia Columns Blogs Analysis Commentary NPR Ombudsman Topic Index Sponsor NPR NPR Shop About NPR Jobs & Training Press Releases Copyright NPR Terms of Use Privacy Policy Permissions Corrections Text-Only Site Help Contact Us Donate Our partner in public broadcasting pbs

Tuesday, June 15, 2010

Obama, Democrats Launch Health Care Push

by Scott Horsley

June 8, 2010

Listen to the Story All Things Considered

[3 min 54 sec] Add to Playlist Download   text size A A A June 8, 2010

With a speech on Tuesday, President Obama rolls out the first stages of implementing the health care overhaul. The public remains ambivalent about the new law, but polls suggest most are willing to let it play out before judging it. The administration and its Democratic Party allies are launching a campaign to sell it to the American people.

Copyright © 2010 National Public Radio®. For personal, noncommercial use only. See Terms of Use. For other uses, prior permission required.

ROBERT SIEGEL, host:

From NPR News, it's ALL THINGS CONSIDERED. Im Robert Siegel.

Remember health care? More than two months after passage of a sweeping overhaul, many Americans are still skeptical of or downright opposed to the law.

As NPR's Scott Horsley reports, President Obama and his allies are now mounting a major effort to defend the measure.

SCOTT HORSLEY: President Obama held a telephone town hall meeting today for seniors, who are the most concerned about health care and any changes to their own coverage.

He was introduced by Fran Garfinkle, a cancer survivor whose costly drugs have put her into the so-called donut hole - thats the gap in Medicare's prescription drug benefit, where seniors have to pay for their own medication.

Ms. FRAN GARFINKLE: It's pretty scary. I understand now how just one serious medical setback can cause one to lose their home, and to use their savings and their retirement fund.

HORSLEY: The president promised some relief for Garfinkle and the estimated four million seniors who will find themselves in the donut hole this year. Under the new health care law, theyll each receive a $250 check to help cover the cost of their medication. The first of those checks go out later this week.

President BARACK OBAMA: Beginning next year, if you fall into the coverage gap you'll get a 50 percent discount on the brand name medicine that you need - 50 percent.

(Soundbite of applause)

HORSLEY: The administration is actively promoting the drug rebate checks and other benefits for seniors. The White House hired campaign strategist Stephanie Cutter to oversee its sales push. She admits it's an uphill battle, given Republican success in characterizing the law as too costly and risky.

Ms. STEPHANIE CUTTER (Assistant to the President, Special Projects): We may be starting from a couple of steps back from where we need to be, but we're going to get it done. We're going to communicate with seniors all the things they need to know under the law.

HORSLEY: The administration is getting some help from groups like AARP, which lobbied for the new law and has now sent mailings about it to nearly 40 million members. The group's vice president, Nancy LeaMond, says for many seniors ideological opposition is giving way to practical questions about how the law will work.

Ms. NANCY LEAMOND (Executive Vice President, AARP): Particularly for America's seniors, the focus now really is on finding out what it means to them.

HORSLEY: LeaMond knows it took years to educate seniors about the Prescription Drug Benefit, and the health care overhaul is considerably more involved.

Supporters are also launching a new non-profit group to defend the law and the politicians behind it. The Health Information Center is being organized by veteran Democratic strategists and bankrolled with up to $25 million this year, from unions, foundations and corporate contributors.

If all this sounds a little defensive for what is, after all, the law of the land, Harvard analyst Robert Blendon says there's a good reason.

Professor ROBERT BLENDON (Health Policy and Political Analysis, Harvard University): There is a continuing debate around this law because the majority of Americans have not come to the judgment that it's the right thing to do.

HORSLEY: Blendon says it's hard for people to reach that judgment because most of the law hasnt taken effect yet. The administration is trying to speed up some of the more popular early provisions, like the ban on lifetime insurance limits and the requirement that insurance companies cover sick children.

Prof. BLENDON: I think the administration is trying to put facts on the ground. But much of this legislation does not take effect for years, and that makes it harder for people to be absolutely supportive of its continuation.

HORSLEY: Republicans are actively campaigning for repeal of the health care law. But even though more Americans disapprove of the measure than support it, a Wall Street Journal poll last month found most want to give the overhaul a chance to work and make changes as needed.

In order to sell the new law as a major accomplishment, Democrats need to build public support for it. And the White House is convinced that as people grow accustomed to the benefits in the law, it will be harder for opponents to take them away.

Scott Horsley, NPR News, Washington.

Copyright © 2010 National Public Radio®. All rights reserved. No quotes from the materials contained herein may be used in any media without attribution to National Public Radio. This transcript is provided for personal, noncommercial use only, pursuant to our Terms of Use. Any other use requires NPR's prior permission. Visit our permissions page for further information.

NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR's programming is the audio.

  E-mail Share Comments Print Facebook Stumble Upon Reddit Twitter Digg What is this?

Share   Health Care Rising Costs: A Health Care Challenge For DemocratsMoney Worries Keep Cancer Survivors From Getting CareBoth Parties Try To Score Points Off Health Care Law Podcast + RSS Feeds Podcast RSS Health Care

Subscribe to Health Care podcast via:

iTunesZune

Or use this URL:

This podcast

close

    All Things Considered–         Comments Discussions for this story are now closed. Please see the Community FAQ for more information.

  Recent First Oldest First Most Recommended View all comments »

Shots - Health News Blog: The NPR Health BlogKeeping Gulf Seafood Safe To Eat Poses A Big ChallengeIncrease In Drug-Resistant Infections Sparks Call For Global ActionFederal Nutrition Panel Urges More Cuts In Salt, Sugar For Better Healthmore

  npr always on Newsletters Podcasts Mobile RSS Feeds Widgets API Radio news U.S. World Opinion Politics Business Technology Science Health Sports arts & life Books Movies Pop Culture Food Performing Arts Games & Humor music Concerts You Must Hear This Interviews & Profiles Music News Music BlogsRock/Pop/FolkJazz & BluesClassical Browse Artists A-Z All Songs ConsideredFrom The Top JazzSet Marian McPartland's Piano Jazz Mountain StageSong of the DayThe Thistle & Shamrock World Cafe World Of Opera programs a-z Morning Edition All Things Considered Fresh Air The Diane Rehm Show On The Media On Point Talk of the Nation Tell Me More Weekend Edition Saturday Weekend Edition Sunday Car Talk Wait Wait...Don't Tell Me! listen Hourly News NPR Program Stream Schedule Find Station Streams more Multimedia Columns Blogs Analysis Commentary NPR Ombudsman Topic Index Sponsor NPR NPR Shop About NPR Jobs & Training Press Releases Copyright NPR Terms of Use Privacy Policy Permissions Corrections Text-Only Site Help Contact Us Donate Our partner in public broadcasting pbs

GOP Stalls Nomination For Leader of Medicare Agency

by Julie Rovner

June 9, 2010

Listen to the Story Morning Edition

[4 min 3 sec] Add to Playlist Download Transcript   Donald Berwick awaits Senate confirmation before he can take over as administrator of the CMS. Courtesy of Donald Berwick

Donald Berwick awaits Senate confirmation before he can take over as administrator of the Centers for Medicare and Medicaid Services.

text size A A A June 9, 2010

Call it a tale of two Donalds.

Dr. Donald Berwick is President Obama's pick to head the Centers for Medicare and Medicaid Services. It's not only the agency that oversees the nation's two largest health care programs, but the one that will play a pivotal role in implementing the new health care law.

Berwick, a mild-mannered Harvard pediatrician who is also the founder of the Boston-based Institute for Healthcare Improvement, is something of a rock star in health policy circles. Most major health industry groups back Berwick's nomination — as do the Democratic and Republican predecessors who have run the agency before.

"Don is a person who's spent his entire career committed not just to talking about ways to make health care better, but actually helping organizations around the country change health care for the better," says Mark McClellan, who headed CMS under President George W. Bush. "And that's exactly the kind of background that CMS needs right now in order to find better ways to support high-quality care while saving money at the same time."

The Donald Republicans See

But that's not the Donald Berwick that Republican senators have been describing on the Senate floor. They say he's out to transform the U.S. health care system into one like England's — and not in a good way.

Roberts says Berwick has praised the workings of Britain's National Health Service. Enlarge Charles Dharapak/AP

Sen. Pat Roberts and several other Republican senators have been hammering on the fact that among his voluminous writings, Donald Berwick has praised the workings of Britain's National Health System.

Roberts says Berwick has praised the workings of Britain's National Health Service. Charles Dharapak/AP Sen. Pat Roberts and several other Republican senators have been hammering on the fact that among his voluminous writings, Donald Berwick has praised the workings of Britain's National Health System.

"Dr. Berwick is the perfect nominee for a president whose aim has always been to save money by rationing health care," Sen. Pat Roberts (R-KS) says.

Sen. John Barrasso (R-WY) agrees.

"Do I really want Dr. Berwick? Do I want somebody who is in love with the National Health Service of Britain — someone who says they have incredible respect for the way it works and thinks it's the right way to go? Why would an American citizen want that person to be in charge of Medicare and Medicaid for this country?" Barrasso says.

In fact, while Berwick did profess his love for the British system in a speech two years ago on the 60th anniversary of the National Health Service, most of the rest of his address consisted of ways that system could use improvement. And he's not been an advocate of imposing such a system here.

Democrats: GOP Rehashing Health Care Debate

Health and Human Services Secretary Kathleen Sebelius says Republicans are raising roadblocks to Berwick's appointment less because of what they think he actually represents and more in an effort to keep the debate on the new health law alive.

"I think if you look at some of the criticism, it has less to do with Dr. Berwick and his qualifications and his leadership abilities and more to do with rehashing some of the arguments that those same members made against the legislation in the first place," Sebelius says.

Neera Tanden, a former Obama administration health official now at the Center for American Progress, says holding up Berwick's appointment by accusing him of having a hidden rationing agenda actually accomplishes several simultaneous goals for Republicans.

"One, it scares people," Tanden says. "Two, it really deprives the agency of one of the premiere thinkers in the strategy because he's silent during the process; he can't write extensively, he can't comment, and he's not there" at HHS.

Tanden, however, says Democrats have a problem of their own making: While Republicans are keeping up an unrelenting public drumbeat against the new law, Democrats have tried to move on to other subjects, particularly jobs.

"So the question for them is whether they can actually walk and chew gum — defend their vote, defend the [health care] legislation, and talk about economic issues in their district," Tanden says.

If they can't, she says, things may look grim for the Democrats come Election Day.

Related NPR Stories The Most Dangerous Desk Jobs In Washington June 3, 2010 Providing Better Health Care For Less Money July 22, 2009 Pursuing Comprehensive Health Coverage in the U.S. Dec. 14, 2007   E-mail Share Comments Print Facebook Stumble Upon Reddit Twitter Digg What is this?

Share   Health Care Rising Costs: A Health Care Challenge For DemocratsMoney Worries Keep Cancer Survivors From Getting CareBoth Parties Try To Score Points Off Health Care Law Podcast + RSS Feeds Podcast RSS Health Care

Subscribe to Health Care podcast via:

iTunesZune

Or use this URL:

This podcast

close

    Tracking The Overhaul

Subscribe to Tracking The Overhaul podcast via:

iTunesZune

Or use this URL:

This podcast

close

          Comments

Please note that all comments must adhere to the NPR.org discussion rules and terms of use. See also the Community FAQ.

You must be logged in to leave a comment. Login | Register

More information is required for you to participate in the NPR online community. Add this information

Post this comment to Facebook, too?  

NPR reserves the right to read on the air and/or publish on its Web site or in any medium now known or unknown the e-mails and letters that we receive. We may edit them for clarity or brevity and identify authors by name and location. For additional information, please consult our Terms of Use.

  Recent First Oldest First Most Recommended View all comments »

Shots - Health News Blog: The NPR Health BlogKeeping Gulf Seafood Safe To Eat Poses A Big ChallengeIncrease In Drug-Resistant Infections Sparks Call For Global Actionmore

Rx For Change: Legislation Rising Costs: A Health Care Challenge For DemocratsSome Recent Grads Face Health Care Coverage Gap Health Care Explainer (300x90) Tracking The Overhaul What Health Care Overhaul Means For You

Interactive: How exactly would new health care overhaul legislation affect you?

  npr always on Newsletters Podcasts Mobile RSS Feeds Widgets API Radio news U.S. World Opinion Politics Business Technology Science Health Sports arts & life Books Movies Pop Culture Food Performing Arts Games & Humor music Concerts You Must Hear This Interviews & Profiles Music News Music BlogsRock/Pop/FolkJazz & BluesClassical Browse Artists A-Z All Songs ConsideredFrom The Top JazzSet Marian McPartland's Piano Jazz Mountain StageSong of the DayThe Thistle & Shamrock World Cafe World Of Opera programs a-z Morning Edition All Things Considered Fresh Air The Diane Rehm Show On The Media On Point Talk of the Nation Tell Me More Weekend Edition Saturday Weekend Edition Sunday Car Talk Wait Wait...Don't Tell Me! listen Hourly News NPR Program Stream Schedule Find Station Streams more Multimedia Columns Blogs Analysis Commentary NPR Ombudsman Topic Index Sponsor NPR NPR Shop About NPR Jobs & Training Press Releases Copyright NPR Terms of Use Privacy Policy Permissions Corrections Text-Only Site Help Contact Us Donate Our partner in public broadcasting pbs